Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Equities
688192
CNE1000055W8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.39 CNY | +3.26% | +25.40% | -7.23% |
Business Summary
Number of employees: 424
Managers
Managers | Title | Age | Since |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Qing Bei Zeng
CTO | Chief Tech/Sci/R&D Officer | 62 | 17-11-30 |
Zhen Fan Yang
CTO | Chief Tech/Sci/R&D Officer | 56 | 17-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 17-09-30 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 20-09-06 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 20-09-07 |
Xin Zhang
BRD | Director/Board Member | 52 | 20-09-07 |
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 17-10-26 |
Director/Board Member | 51 | 17-09-30 | |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 20-06-30 |
Bin Jiang
BRD | Director/Board Member | 60 | 20-09-07 |
Wei Wen Dong
CHM | Chairman | 38 | 18-05-31 |
- | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 415,653,120 | 76,821,862 ( 18.48 %) | 0 | 18.48 % |
Company contact information
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Building 4 199, 245 Liangjing Road
201203, Shanghai
+
http://www.dizalpharma.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.23% | 2.55B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 688192 Stock
- Company Dizal (Jiangsu) Pharmaceutical Co., Ltd.